Unknown

Dataset Information

0

Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.


ABSTRACT: We report the absolute binding free energy calculation and surface plasmon resonance (SPR) experiment for ligand binding with the c-MYC G-quadruplex DNA. The unimolecular parallel DNA G-quadruplex formed in nuclease hypersensitivity element III1 of the c-MYC gene promoter regulates the c-MYC transcription and is recognized as an emerging drug target for cancer therapy. Quindoline derivatives have been shown to stabilize the G-quadruplex and inhibit the c-MYC expression in cancer cells. NMR revealed two binding sites located at the 5' and 3' termini of the G-quadruplex. Questions about which site is more favored and the basis for the ligand-induced binding site formation remain unresolved. Here, we employ two absolute binding free energy methods, the double decoupling and the potential of mean force methods, to dissect the ligand-binding specificity in the c-MYC G-quadruplex. The calculated absolute binding free energies are in general agreement with the SPR result and suggest that quindoline has a slight preference for the 5' site. The flanking residues around the two sites undergo significant reorganization as the ligand unbinds, which provides evidence for ligand-induced binding pocket formation. The results help interpret experimental data and inform rational design of small molecules targeting the c-MYC G-quadruplex.

SUBMITTER: Deng N 

PROVIDER: S-EPMC5825213 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.

Deng Nanjie N   Wickstrom Lauren L   Cieplak Piotr P   Lin Clement C   Yang Danzhou D  

The journal of physical chemistry. B 20171109 46


We report the absolute binding free energy calculation and surface plasmon resonance (SPR) experiment for ligand binding with the c-MYC G-quadruplex DNA. The unimolecular parallel DNA G-quadruplex formed in nuclease hypersensitivity element III<sub>1</sub> of the c-MYC gene promoter regulates the c-MYC transcription and is recognized as an emerging drug target for cancer therapy. Quindoline derivatives have been shown to stabilize the G-quadruplex and inhibit the c-MYC expression in cancer cells  ...[more]

Similar Datasets

| S-EPMC5253712 | biostudies-literature
| S-EPMC3557591 | biostudies-literature
| S-EPMC10308817 | biostudies-literature
| S-EPMC2868600 | biostudies-literature
| S-EPMC7806944 | biostudies-literature
| S-EPMC4127432 | biostudies-literature
| S-EPMC3157700 | biostudies-literature
| S-EPMC3285237 | biostudies-literature
| S-EPMC4442669 | biostudies-literature
| S-EPMC8065617 | biostudies-literature